Terence Flynn
Stock Analyst at Morgan Stanley
(4.64)
# 835
Out of 4,423 analysts
1016
Total ratings
58.8%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Rated: Hold | $206 → $224 | $196.58 | +13.95% | 59 | Jun 18, 2026 | |
| AMGN Amgen | Maintained: Hold | $332 → $340 | $337.60 | +0.71% | 53 | Jun 10, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,344 | $1,098.57 | +22.34% | 78 | Jun 8, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $36 | $17.55 | +105.13% | 17 | Jun 8, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $168 | $123.76 | +35.75% | 58 | Jun 4, 2026 | |
| UTHR United Therapeutics | Maintained: Hold | $516 | $536.59 | -3.84% | 33 | Jun 4, 2026 | |
| ABBV AbbVie | Maintained: Buy | $278 | $216.49 | +28.41% | 52 | May 31, 2026 | |
| BHVN Biohaven | Maintained: Buy | $18 | $13.57 | +32.65% | 18 | May 28, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Sell | $40 | $54.00 | -25.93% | 48 | May 26, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $126 | $90.89 | +38.63% | 84 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $39 | $23.41 | +66.60% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $15.67 | -4.28% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $48 | $27.93 | +71.86% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.23 | - | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $22 | $24.31 | -9.50% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $64 | $52.96 | +20.85% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $25.21 | +11.07% | 57 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $612 → $616 | $451.63 | +36.39% | 52 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $112 | $113.87 | -1.64% | 52 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $30 → $33 | $63.96 | -48.41% | 32 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $796 → $788 | $609.94 | +29.19% | 57 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $267 → $283 | $228.39 | +23.91% | 54 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $13.43 | -32.99% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $7.67 | +43.42% | 24 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $126 | $44.51 | +183.08% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $32 → $33 | $54.09 | -38.99% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.15 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.69 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16 | $44.99 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $12 | $2.95 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €91.62 | $132.90 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.43 | $6.57 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $82.49 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 → $155 | $278.09 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $55.11 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $6.76 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $34.16 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $10.07 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $6.61 | n/a | 1 | Jul 21, 2015 |
Biogen
Jun 18, 2026
Rated: Hold
Price Target: $206 → $224
Current: $196.58
Upside: +13.95%
Amgen
Jun 10, 2026
Maintained: Hold
Price Target: $332 → $340
Current: $337.60
Upside: +0.71%
Eli Lilly and Company
Jun 8, 2026
Maintained: Buy
Price Target: $1,344
Current: $1,098.57
Upside: +22.34%
Nurix Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $36
Current: $17.55
Upside: +105.13%
Gilead Sciences
Jun 4, 2026
Maintained: Buy
Price Target: $168
Current: $123.76
Upside: +35.75%
United Therapeutics
Jun 4, 2026
Maintained: Hold
Price Target: $516
Current: $536.59
Upside: -3.84%
AbbVie
May 31, 2026
Maintained: Buy
Price Target: $278
Current: $216.49
Upside: +28.41%
Biohaven
May 28, 2026
Maintained: Buy
Price Target: $18
Current: $13.57
Upside: +32.65%
Bristol-Myers Squibb Company
May 26, 2026
Maintained: Sell
Price Target: $40
Current: $54.00
Upside: -25.93%
BioNTech SE
May 18, 2026
Maintained: Buy
Price Target: $126
Current: $90.89
Upside: +38.63%
May 15, 2026
Maintained: Buy
Price Target: $38 → $39
Current: $23.41
Upside: +66.60%
May 13, 2026
Maintained: Hold
Price Target: $15
Current: $15.67
Upside: -4.28%
May 13, 2026
Maintained: Buy
Price Target: $49 → $48
Current: $27.93
Upside: +71.86%
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $3.23
Upside: -
May 11, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $24.31
Upside: -9.50%
May 7, 2026
Maintained: Buy
Price Target: $63 → $64
Current: $52.96
Upside: +20.85%
May 6, 2026
Maintained: Hold
Price Target: $28
Current: $25.21
Upside: +11.07%
May 5, 2026
Rated: Buy
Price Target: $612 → $616
Current: $451.63
Upside: +36.39%
May 1, 2026
Maintained: Hold
Price Target: $109 → $112
Current: $113.87
Upside: -1.64%
May 1, 2026
Rated: Hold
Price Target: $30 → $33
Current: $63.96
Upside: -48.41%
Apr 30, 2026
Maintained: Hold
Price Target: $796 → $788
Current: $609.94
Upside: +29.19%
Apr 15, 2026
Rated: Buy
Price Target: $267 → $283
Current: $228.39
Upside: +23.91%
Apr 10, 2026
Maintained: Hold
Price Target: $9
Current: $13.43
Upside: -32.99%
Mar 18, 2026
Maintained: Hold
Price Target: $11
Current: $7.67
Upside: +43.42%
Feb 27, 2026
Maintained: Buy
Price Target: $125 → $126
Current: $44.51
Upside: +183.08%
Feb 17, 2026
Maintained: Sell
Price Target: $32 → $33
Current: $54.09
Upside: -38.99%
Sep 21, 2025
Maintained: Hold
Price Target: n/a
Current: $4.15
Upside: -
Dec 13, 2024
Maintained: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Jun 1, 2021
Maintained: Sell
Price Target: $16
Current: $44.99
Upside: n/a
Aug 10, 2020
Maintained: Hold
Price Target: $21 → $12
Current: $2.95
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €91.62
Current: $132.90
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.43
Current: $6.57
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $82.49
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $163 → $155
Current: $278.09
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $55.11
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $6.76
Upside: n/a
Jun 13, 2016
Maintained: Hold
Price Target: $46
Current: $34.16
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $10.07
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $6.61
Upside: n/a